Meridian Bioscience. (NSDQ: VIVO) added Mar 28, 2011
Meridian Bioscience is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Our products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections.
In addition, we develop and manufacture a variety of biological and non-biological materials used in proficiency testing programs. Learn more about our Proficiency & Controls business unit.
Meridian diagnostic products are used outside of the human body and require little or no special equipment. We design our products to enhance the well being of the patient—while reducing the total outcome costs of healthcare.
Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis. We actively market our products to hospitals, reference laboratories, research centers, physician offices and diagnostics manufacturers in more than 60 countries around the world.
Recent News: Meridian Bioscience Receives FDA Clearance For New illumigene® C. difficile Pediatric Claim
Jeffrey Frelick .....Canaccord/Genuity….Mar 25, 2011
Upgraded to BUY from HOLD
Target raised to $30.00 from $21.00US
VIVO Price day before:$22.27Finish day posting$23.20Current $23.20
----Nov 16, 2010------
New HOLD
Target $21.00US
VIVO Price day before:$22.63Finish day posting$22.02Current $23.20
******************
Brian Weinstein .....William Blair and Company….Mar 25, 2011
Maintained MARKET PERFORM
VIVO Price day before:$22.27Finish day posting$23.20Current $23.20
******************
Quintin J. Lai, Ph.D .....Robert W. Baird & Company….Nov 11, 2010
Maintained OUTPERFORM
Target raised to $26.00 from $25.00US
VIVO Price day before:$23.89Finish day posting$22.83Current $23.20
******************